{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:42:00Z","timestamp":1783795320170,"version":"3.55.0"},"reference-count":216,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.autrev.2022.103166","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T02:35:04Z","timestamp":1659580504000},"page":"103166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The mosaic of autoimmunity \u2013 Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens"],"prefix":"10.1016","volume":"21","author":[{"given":"Naim","family":"Mahroum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Elsalti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkarim","family":"Alwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isa","family":"Seida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Alrais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravend","family":"Seida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sevval Nil","family":"Esirgun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunahan","family":"Abali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Kiyak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdi","family":"Zoubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0005","first-page":"425","article-title":"The 13th international congress on autoimmunity 2022 (AUTO13) Athens: an event as big as the topics","volume":"24","author":"Elsalti","year":"2022","journal-title":"IMAJ"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103037","article-title":"Myocarditis in systemic immune-mediated diseases: prevalence, characteristics and prognosis. A systematic review","volume":"21","author":"Cheng","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103073","article-title":"Renal autoimmunity: The role of bacterial and viral infections, an extensive review","volume":"21","author":"Lavine","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0020","doi-asserted-by":"crossref","first-page":"102945","DOI":"10.1016\/j.autrev.2021.102945","article-title":"The mosaic of autoimmunity - a taste for more. The 12th international congress of autoimmunity 2021 (AUTO12) virtual","volume":"20","author":"Mahroum","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102792","article-title":"The SARS-CoV-2 as an instrumental trigger of autoimmunity","volume":"20","author":"Dotan","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102865","article-title":"Autoimmunity and COVID-19 - the microbiotal connection","volume":"20","author":"Katz-Agranov","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0035","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1006\/jaut.1996.0091","article-title":"Vaccine-induced autoimmunity","volume":"9","author":"Cohen","year":"1996","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0040","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/cmi.2017.151","article-title":"Vaccine-induced autoimmunity: the role of molecular mimicry and immune crossreaction","volume":"15","author":"Segal","year":"2018","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.872683","article-title":"COVID-19 vaccination and the rate of immune and autoimmune adverse events following immunization: insights from a narrative literature review","volume":"13","author":"Mahroum","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0050","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1001\/jama.1987.03400020046020","article-title":"What's a joint like that doing on a nice girl like you?","volume":"258","author":"Dlesk","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2022.103166_bb0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.5116\/ijme.5fb9.1c9b","article-title":"The power of observation in clinical medicine","volume":"11","author":"Faustinella","year":"2020","journal-title":"Int J Med Educ"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0060","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0065","doi-asserted-by":"crossref","first-page":"R28","DOI":"10.1186\/ar2622","article-title":"Diagnostic value of anti-topoisomerase I antibodies in a large monocentric cohort","volume":"11","author":"Hanke","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103166_bb0070","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: a comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2022.103166_bb0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2147\/TACG.S213920","article-title":"Autoimmunity in Wiskott-Aldrich syndrome: updated perspectives","volume":"14","author":"Sudhakar","year":"2021","journal-title":"Appl Clin Genet"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb0080","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ni.1900","article-title":"Control systems and decision making for antibody production","volume":"11","author":"Goodnow","year":"2010","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2016.09.042","article-title":"Human regulatory B cells control the TFH cell response","volume":"140","author":"Achour","year":"2017","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0090","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12931-019-1216-6","article-title":"Aberrant populations of circulating T follicular helper cells and regulatory B cells underlying idiopathic pulmonary fibrosis","volume":"20","author":"Asai","year":"2019","journal-title":"Respir Res"},{"key":"10.1016\/j.autrev.2022.103166_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.785549","article-title":"Crosstalk between circulating follicular T helper cells and regulatory B cells in children with extrinsic atopic dermatitis","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb0100","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41423-019-0227-z","article-title":"IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjogren\u2019s syndrome","volume":"16","author":"Lin","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb0105","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.autrev.2018.04.005","article-title":"The role of stress in the mosaic of autoimmunity: an overlooked association","volume":"17","author":"Sharif","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0110","doi-asserted-by":"crossref","first-page":"237","DOI":"10.21101\/cejph.a5650","article-title":"Consequences of holocaust on physical health of survivors: bibliography review","volume":"28","author":"Horackova","year":"2020","journal-title":"Cent Eur J Public Health"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0115","first-page":"670","article-title":"Hoarding among Jewish holocaust survivors: moving toward a theoretical model","volume":"20","author":"Porat-Katz","year":"2018","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0120","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/BOR.0000000000000107","article-title":"New autoantibody detection technologies yield novel insights into autoimmune disease","volume":"26","author":"Burbelo","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-022-08931-3","article-title":"Clinical significance of antinucleolar antibodies: biomarkers for autoimmune diseases, malignancies, and others","author":"Satoh","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb0130","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1056\/NEJM200009213431204","article-title":"Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies","volume":"343","author":"Vernino","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0135","doi-asserted-by":"crossref","first-page":"e397","DOI":"10.1212\/CPJ.0000000000001047","article-title":"Ganglionic acetylcholine receptor antibodies in postural tachycardia syndrome","volume":"11","author":"Bryarly","year":"2021","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.autrev.2022.103166_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577399","article-title":"Antibodies to the alpha3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis","volume":"349","author":"Yamakawa","year":"2020","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0145","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001162","article-title":"Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy","volume":"9","author":"Karagiorgou","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0150","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002099","article-title":"Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein\/peptide antibodies test results","volume":"8","author":"Van Hoovels","year":"2022","journal-title":"RMD Open"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102583","article-title":"Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets","volume":"19","author":"Mahler","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0160","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1373\/clinchem.2017.275677","article-title":"Current and emerging multianalyte assays with algorithmic analyses-are laboratories ready for clinical adoption?","volume":"64","author":"Colon-Franco","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/j.autrev.2022.103166_bb0165","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.3389\/fimmu.2018.02682","article-title":"The utilization of autoantibodies in approaches to precision health","volume":"9","author":"Fritzler","year":"2018","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrrheum.2018.56","article-title":"Autoantibodies in myositis","volume":"14","author":"McHugh","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jaut.2014.01.019","article-title":"The diagnosis and classification of undifferentiated connective tissue diseases","volume":"48-49","author":"Mosca","year":"2014","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb0180","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.autrev.2007.02.006","article-title":"Associated autoantibodies in celiac disease","volume":"6","author":"Shaoul","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102946","article-title":"The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases","volume":"20","author":"Jara","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26010184","article-title":"Macrophage migration inhibitory factor (MIF) and its homologue d-dopachrome tautomerase (DDT) inversely correlate with inflammation in discoid lupus erythematosus","volume":"26","author":"Caltabiano","year":"2021","journal-title":"Molecules."},{"issue":"14","key":"10.1016\/j.autrev.2022.103166_bb0195","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1177\/0961203317706557","article-title":"Clinical associations of proinflammatory cytokines, oxidative biomarkers and vitamin D levels in systemic lupus erythematosus","volume":"26","author":"Willis","year":"2017","journal-title":"Lupus."},{"key":"10.1016\/j.autrev.2022.103166_bb0200","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211025894","article-title":"Immunomodulation with IL-17 and TNF-alpha in spondyloarthritis: focus on the eye and the central nervous system","volume":"13","author":"How Shing Koy","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"31","key":"10.1016\/j.autrev.2022.103166_bb0205","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.12998\/wjcc.v9.i31.9333","article-title":"Pharmaconutrition strategy to resolve SARS-CoV-2-induced inflammatory cytokine storm in non-alcoholic fatty liver disease: Omega-3 long-chain polyunsaturated fatty acids","volume":"9","author":"Jeyakumar","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.autrev.2022.103166_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.109935","article-title":"IL-17A and TNF-alpha as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19","volume":"144","author":"Leija-Martinez","year":"2020","journal-title":"Med Hypotheses"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102932","article-title":"Autoimmunity in vitiligo: Therapeutic implications and opportunities","volume":"21","author":"Khaitan","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0220","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/BOR.0000000000000633","article-title":"Complement, infection, and autoimmunity","volume":"31","author":"Conigliaro","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0225","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1874312901711010113","article-title":"SLE and serum complement: causative, concomitant or coincidental?","volume":"11","author":"Sandhu","year":"2017","journal-title":"Open Rheumatol J"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0230","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11926-021-00984-1","article-title":"A review of complement activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0235","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000528","article-title":"A multianalyte assay panel with cell-bound complement activation products demonstrates clinical utility in systemic lupus erythematosus","volume":"8","author":"Alexander","year":"2021","journal-title":"Lupus Sci Med"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb0240","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.autrev.2016.07.020","article-title":"Complement and thrombosis in the antiphospholipid syndrome","volume":"15","author":"Oku","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0245","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0250","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0255","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060671","article-title":"Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies","volume":"9","author":"Nalli","year":"2021","journal-title":"Biomedicines."},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0260","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cei.13515","article-title":"The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy","volume":"202","author":"Trivioli","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155873","article-title":"SARS-CoV-2 triggering autoimmune diseases","volume":"154","author":"Mobasheri","year":"2022","journal-title":"Cytokine."},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0270","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41467-022-28905-5","article-title":"Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity","volume":"13","author":"Cabral-Marques","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0275","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/S2665-9913(21)00322-2","article-title":"Therapeutic implications of ongoing alveolar viral replication in COVID-19","volume":"4","author":"McGonagle","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102778","article-title":"Ferritin - from iron, through inflammation and autoimmunity, to COVID-19","volume":"126","author":"Mahroum","year":"2022","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0285","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/00325481.2021.1990091","article-title":"Ferritin as prognostic marker in COVID-19: the FerVid study","volume":"134","author":"Para","year":"2022","journal-title":"Postgrad Med"},{"key":"10.1016\/j.autrev.2022.103166_bb0290","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cca.2021.12.011","article-title":"Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types","volume":"525","author":"Nevejan","year":"2022","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0295","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00011-021-01516-4","article-title":"Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study)","volume":"71","author":"Garcia de Guadiana-Romualdo","year":"2022","journal-title":"Inflamm Res"},{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0300","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa276","article-title":"Subacute thyroiditis after sars-COV-2 infection","volume":"105","author":"Brancatella","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1756-185X.14259","article-title":"COVID-19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age-associated B cells","volume":"25","author":"Mahroum","year":"2022","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103166_bb0310","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac322","article-title":"Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis","author":"Blank","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2022.103166_bb0315","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.thromres.2021.11.030","article-title":"Detection of anti-GPIbalpha autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination","volume":"209","author":"Nakamura","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.autrev.2022.103166_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.108979","article-title":"Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 response","volume":"237","author":"Renaudineau","year":"2022","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0325","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3899\/jrheum.210788","article-title":"Vasculitis as temporally associated with COVID-19 infection or vaccination: a single-center experience","volume":"49","author":"Hocevar","year":"2022","journal-title":"J Rheumatol"},{"issue":"27","key":"10.1016\/j.autrev.2022.103166_bb0330","doi-asserted-by":"crossref","first-page":"977","DOI":"10.15585\/mmwr.mm7027e2","article-title":"Use of mRNA COVID-19 vaccine after reports of myocarditis among vaccine recipients: update from the advisory committee on immunization practices - United States, June 2021","volume":"70","author":"Gargano","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0335","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCULATIONAHA.121.056135","article-title":"Myocarditis with COVID-19 mRNA vaccines","volume":"144","author":"Bozkurt","year":"2021","journal-title":"Circulation."},{"key":"10.1016\/j.autrev.2022.103166_bb0340","article-title":"Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell\u2019s palsy: a population-based study","volume":"11","author":"Shibli","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.autrev.2022.103166_bb0345","article-title":"COVID-19 vaccination and Guillain-Barre syndrome: analyses using the National Immunoglobulin Database","author":"Keh","year":"2022","journal-title":"Brain."},{"key":"10.1016\/j.autrev.2022.103166_bb0350","first-page":"2036460","article-title":"A case of autoimmune hemolytic anemia after the first dose of COVID-19 mRNA-1273 vaccine with undetected pernicious anemia","volume":"2022","author":"Jaydev","year":"2022","journal-title":"Case Rep Hematol"},{"key":"10.1016\/j.autrev.2022.103166_bb0355","article-title":"Severe relapsed autoimmune hemolytic anemia after booster with mRNA-1273 COVID-19 vaccine","author":"Mesina","year":"2022","journal-title":"Hematol Transfus Cell Ther"},{"key":"10.1016\/j.autrev.2022.103166_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102827","article-title":"High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients","volume":"129","author":"Fabris","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103166_bb0365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.868915","article-title":"Humoral and cellular immune responses to SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis: an Israeli multi-center experience following 3 vaccine doses","volume":"13","author":"Milo","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0370","doi-asserted-by":"crossref","first-page":"102947","DOI":"10.1016\/j.autrev.2021.102947","article-title":"Post-COVID syndrome. A case series and comprehensive review","volume":"20","author":"Anaya","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103166_bb0375","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103012","article-title":"Autoantibodies and SARS-CoV2 infection: the spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies","volume":"21","author":"Damoiseaux","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0385","doi-asserted-by":"crossref","first-page":"316","DOI":"10.7150\/thno.49713","article-title":"Immunopathogenesis and treatment of cytokine storm in COVID-19","volume":"11","author":"Kim","year":"2021","journal-title":"Theranostics."},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/cells11050847","article-title":"Severe COVID-19 Shares a common neutrophil activation signature with other acute inflammatory states","volume":"11","author":"Schimke","year":"2022","journal-title":"Cells."},{"key":"10.1016\/j.autrev.2022.103166_bb0395","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.18202","article-title":"Association between COVID-19 vaccination and autoimmune bullous diseases: a random coincidence or rare event","author":"Kasperkiewicz","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2022.103166_bb0400","doi-asserted-by":"crossref","first-page":"773","DOI":"10.3389\/fimmu.2019.00773","article-title":"Blood cell-bound C4d as a marker of complement activation in patients with the antiphospholipid syndrome","volume":"10","author":"Lonati","year":"2019","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.autrev.2022.103166_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21238972","article-title":"The weight of IgA anti-beta2glycoprotein I in the antiphospholipid syndrome pathogenesis: closing the gap of seronegative antiphospholipid syndrome","volume":"21","author":"Cabrera-Marante","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2022.103166_bb0410","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3389\/fimmu.2018.02644","article-title":"Presence of immune complexes of IgG\/IgM bound to B2-glycoprotein I is associated with non-criteria clinical manifestations in patients with antiphospholipid syndrome","volume":"9","author":"Perez","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0415","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3389\/fimmu.2019.01948","article-title":"Triple antiphospholipid (aPL) antibodies positivity is associated with pregnancy complications in aPL carriers: a multicenter study on 62 pregnancies","volume":"10","author":"Lazzaroni","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0420","doi-asserted-by":"crossref","first-page":"123304","DOI":"10.1016\/j.talanta.2022.123304","article-title":"Monitoring autoimmune diseases by bioelectrochemical detection of autoantibodies. Application to the determination of anti-myelin basic protein autoantibodies in serum of multiple sclerosis patients","volume":"243","author":"Guerrero","year":"2022","journal-title":"Talanta."},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0425","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00726-021-03111-7","article-title":"Multiple sclerosis and myelin basic protein: insights into protein disorder and disease","volume":"54","author":"Martinsen","year":"2022","journal-title":"Amino Acids"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9080899","article-title":"Anti-phospholipid antibodies and COVID-19 thrombosis: a co-star, not a supporting actor","volume":"9","author":"Gil-Etayo","year":"2021","journal-title":"Biomedicines."},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0435","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061651","article-title":"COVID-19 related coagulopathy: a distinct entity?","volume":"9","author":"Marchandot","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0440","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/acr2.11245","article-title":"Beta-2-glycoprotein-I deficiency could precipitate an antiphospholipid syndrome-like prothrombotic situation in patients with coronavirus disease 2019","volume":"3","author":"Serrano","year":"2021","journal-title":"ACR Open Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0445","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BOR.0000000000000051","article-title":"Targeted therapy in antiphospholipid syndrome","volume":"26","author":"Sciascia","year":"2014","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0450","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/rheumatology\/keaa463","article-title":"Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion","volume":"60","author":"Zen","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0455","first-page":"149","article-title":"Management of maternal antiphospholipid syndrome","volume":"38","author":"Fernandes","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0460","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.4049\/jimmunol.1801235","article-title":"Glatiramer acetate stimulates regulatory B cell functions","volume":"202","author":"Amrouche","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2012.07.005","article-title":"Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus","volume":"40","author":"Hansel","year":"2013","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103166_bb0470","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3389\/fimmu.2019.00948","article-title":"Current concepts on 6-sulfo LacNAc expressing monocytes (slanMo)","volume":"10","author":"Ahmad","year":"2019","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0475","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.rdc.2019.07.004","article-title":"Treat to target in systemic lupus erythematosus","volume":"45","author":"Aringer","year":"2019","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2022.103166_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102633","article-title":"Implication of a lysosomal antigen in the pathogenesis of lupus erythematosus","volume":"120","author":"Wilhelm","year":"2021","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0485","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/art.41768","article-title":"Protein mannosylation as a diagnostic and prognostic biomarker of lupus nephritis: an unusual glycan neoepitope in systemic lupus erythematosus","volume":"73","author":"Alves","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0490","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12026-016-8884-9","article-title":"Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study","volume":"65","author":"Watad","year":"2017","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0495","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147334","article-title":"The CD6\/ALCAM pathway promotes lupus nephritis via T cell-mediated responses","volume":"132","author":"Chalmers","year":"2022","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0500","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-020-15986-3","article-title":"Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities","volume":"11","author":"Stanley","year":"2020","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2019.102406","article-title":"Treatment for refractory lupus nephritis: rituximab vs triple target therapy","volume":"18","author":"Cervera","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102844","article-title":"A new challenge for lupus nephritis management: induction therapy without immunosuppressive maintenance regimen","volume":"20","author":"Roccatello","year":"2021","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0515","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ekir.2021.01.027","article-title":"A prospective study on long-term clinical outcomes of patients with lupus nephritis treated with an intensified B-cell depletion protocol without maintenance therapy","volume":"6","author":"Roccatello","year":"2021","journal-title":"Kidney Int Rep"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb0520","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.autrev.2015.07.017","article-title":"A 4-year observation in lupus nephritis patients treated with an intensified B-lymphocyte depletion without immunosuppressive maintenance treatment-Clinical response compared to literature and immunological re-assessment","volume":"14","author":"Roccatello","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0525","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0530","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.autrev.2016.02.014","article-title":"New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: a prospective study and a review of the literature","volume":"15","author":"Roccatello","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb0535","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1056\/NEJMoa2023325","article-title":"Targeting CD38 with daratumumab in refractory systemic lupus erythematosus","volume":"383","author":"Ostendorf","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0540","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13075-021-02567-y","article-title":"Machine learning model for identifying important clinical features for predicting remission in patients with rheumatoid arthritis treated with biologics","volume":"23","author":"Koo","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0545","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/art.41516","article-title":"Multiomics and machine learning accurately predict clinical response to adalimumab and etanercept therapy in patients with rheumatoid arthritis","volume":"73","author":"Tao","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0550","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12602-021-09802-7","article-title":"Interplay of microbiota and citrullination in the immunopathogenesis of rheumatoid arthritis","volume":"14","author":"Alghamdi","year":"2022","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"11","key":"10.1016\/j.autrev.2022.103166_bb0555","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1136\/annrheumdis-2018-212954","article-title":"Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts","volume":"77","author":"Neumann","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2022.103166_bb0560","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/annrheumdis-2016-210873","article-title":"Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up","volume":"76","author":"Manivel","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103166_bb0565","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685312","article-title":"Autoantibodies in rheumatoid arthritis - laboratory and clinical perspectives","volume":"12","author":"Ronnelid","year":"2021","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102528","article-title":"Rheumatoid arthritis in the elderly: characteristics and treatment considerations","volume":"19","author":"Serhal","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0575","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.trci.2017.10.002","article-title":"Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients","volume":"3","author":"Judge","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"issue":"9","key":"10.1016\/j.autrev.2022.103166_bb0580","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.autrev.2018.04.001","article-title":"Inflammation and dementia: Using rheumatoid arthritis as a model to develop treatments?","volume":"17","author":"Mason","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0585","article-title":"Biomarkers in rheumatoid arthritis","volume":"13","author":"Shapiro","year":"2021","journal-title":"Cureus"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0590","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40744-020-00231-6","article-title":"Efficacy and safety of baricitinib in Chinese rheumatoid arthritis patients and the subgroup analyses: results from study RA-balance","volume":"7","author":"Yang","year":"2020","journal-title":"Rheumatol Ther"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb0595","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/annrheumdis-2019-216852","article-title":"Infections in baricitinib clinical trials for patients with active rheumatoid arthritis","volume":"79","author":"Winthrop","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0600","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1346-8138.2009.00762.x","article-title":"Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis","volume":"37","author":"Hamaguchi","year":"2010","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0605","first-page":"101","article-title":"Candidate proteomic biomarkers in systemic sclerosis discovered using mass-spectrometry: an update of a systematic review (2014-2020)","volume":"59","author":"Balanescu","year":"2021","journal-title":"Rom J Intern Med"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0610","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1114576","article-title":"Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis","volume":"370","author":"van Bon","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0615","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1038\/s41467-019-09683-z","article-title":"CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-alpha production in systemic sclerosis","volume":"10","author":"Lande","year":"2019","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0620","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity."},{"issue":"14","key":"10.1016\/j.autrev.2022.103166_bb0625","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145102","article-title":"Anti-CXCL4 antibody reactivity is present in systemic sclerosis (SSc) and correlates with the SSc type I interferon signature","volume":"21","author":"Lande","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2022.103166_bb0630","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3389\/fimmu.2018.03112","article-title":"Intriguing relationships between cancer and systemic sclerosis: role of the immune system and other contributors","volume":"9","author":"Maria","year":"2018","journal-title":"Front Immunol"},{"issue":"47","key":"10.1016\/j.autrev.2022.103166_bb0635","doi-asserted-by":"crossref","first-page":"E7526","DOI":"10.1073\/pnas.1615990113","article-title":"Systematic autoantigen analysis identifies a distinct subtype of scleroderma with coincident cancer","volume":"113","author":"Xu","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2022.103166_bb0640","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0645","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13075-020-02153-8","article-title":"Inhibition of effector B cells by ibrutinib in systemic sclerosis","volume":"22","author":"Einhaus","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2022.103166_bb0650","article-title":"Anti-Ro\/SSA antibodies and the autoimmune long-QT syndrome","volume":"8","author":"Lazzerini","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0655","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/art.42018","article-title":"Maladaptive autophagy in the pathogenesis of autoimmune epithelitis in Sjogren\u2019s syndrome","volume":"74","author":"Colafrancesco","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102335","article-title":"Autoimmune epithelitis (Sjogren\u2019s syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity","volume":"104","author":"Katsiougiannis","year":"2019","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103099","article-title":"Sjogren syndrome overlapping with ANCA-associated vasculitis: four additional cases and systematic literature review","volume":"21","author":"Coustal","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb0670","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.autrev.2015.04.009","article-title":"ANCA-associated vasculitis in patients with primary Sjogren\u2019s syndrome: detailed analysis of 7 new cases and systematic literature review","volume":"14","author":"Guellec","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb0675","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2019-215777","article-title":"Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjogren\u2019s syndrome?","volume":"79","author":"Couderc","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0680","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/annrheumdis-2018-214764","article-title":"Development and validation of the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis","volume":"78","author":"Ferdowsi","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103166_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152026","article-title":"Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sjogren\u2019s syndrome?","volume":"55","author":"Marketos","year":"2022","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0690","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11916-016-0556-x","article-title":"Fibromyalgia pathogenesis and treatment options update","volume":"20","author":"Chinn","year":"2016","journal-title":"Curr Pain Headache Rep"},{"issue":"15","key":"10.1016\/j.autrev.2022.103166_bb0695","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA."},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0700","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10067-020-05528-z","article-title":"Dorsal root ganglia: fibromyalgia pain factory?","volume":"40","author":"Martinez-Lavin","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0705","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0306-9877(03)00340-2","article-title":"Calculating the etiology of systemic lupus erythematosus","volume":"62","author":"Adhami","year":"2004","journal-title":"Med Hypotheses"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0710","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2217\/ijr.12.4","article-title":"Fatigue in systemic lupus erythematosus","volume":"7","author":"Ahn","year":"2012","journal-title":"Int J Clin Rheumtol"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb0715","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1097\/j.pain.0000000000000676","article-title":"The epidemiology of chronic pain","volume":"157","author":"Macfarlane","year":"2016","journal-title":"Pain."},{"key":"10.1016\/j.autrev.2022.103166_bb0720","series-title":"Chronic Pain Syndrome","author":"Yasaei","year":"2022"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.103015","article-title":"The autoimmune aetiology of unexplained chronic pain","volume":"21","author":"Goebel","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0730","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.autrev.2012.10.015","article-title":"Complex regional pain syndrome, prototype of a novel kind of autoimmune disease","volume":"12","author":"Goebel","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"13","key":"10.1016\/j.autrev.2022.103166_bb0735","doi-asserted-by":"crossref","DOI":"10.1172\/JCI144201","article-title":"Passive transfer of fibromyalgia symptoms from patients to mice","volume":"131","author":"Goebel","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0740","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0745","article-title":"Correspondence on: \u2018what comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern\u2019","author":"Hocevar","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0750","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1053\/j.ajkd.2021.06.016","article-title":"ANCA-associated vasculitis following Pfizer-BioNTech COVID-19 vaccine","volume":"78","author":"Shakoor","year":"2021","journal-title":"Am J Kidney Dis"},{"issue":"23","key":"10.1016\/j.autrev.2022.103166_bb0755","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000029431","article-title":"Relapse of cryoglobulinemic vasculitis with new-onset severe renal involvement in two patients following mRNA COVID-19 vaccination: a case report","volume":"101","author":"Vornicu","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102905","article-title":"New insights into the pathogenesis of giant cell arteritis: mechanisms involved in maintaining vascular inflammation","volume":"11","author":"Greigert","year":"2022","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/cells8070738","article-title":"A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis","volume":"8","author":"Yang","year":"2019","journal-title":"Cells."},{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0770","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"DRW","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2022.103166_bb0775","article-title":"Survival of patients with idiopathic inflammatory myopathies in slovenia","volume":"8","author":"Hocevar","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0780","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/imj.15358","article-title":"Idiopathic inflammatory myopathies: a review","volume":"51","author":"Ashton","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2022.103166_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.151998","article-title":"Myositis-specific autoantibodies in clinical practice: Improving the performance of the immunodot","volume":"55","author":"Bories","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2022.103166_bb0790","doi-asserted-by":"crossref","DOI":"10.1007\/s00296-022-05149-6","article-title":"Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review","author":"Gonzalez","year":"2022","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0795","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1001\/jamadermatol.2016.3976","article-title":"Dermatopulmonary syndrome associated with anti-mda5 antibodies after allogeneic hematopoietic stem cell transplantation","volume":"153","author":"Lepelletier","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0800","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.693017","article-title":"Early high efficacy treatment in multiple sclerosis is the best predictor of future disease activity over 1 and 2 years in a norwegian population-based registry","volume":"12","author":"Simonsen","year":"2021","journal-title":"Front Neurol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0805","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4049\/jimmunol.1801236","article-title":"Phenotypic and Ig repertoire analyses indicate a common origin of IgD(-)CD27(-) double negative B cells in healthy individuals and multiple sclerosis patients","volume":"203","author":"Fraussen","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0810","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.596981","article-title":"Myasthenia gravis: autoantibody specificities and their role in MG management","volume":"11","author":"Lazaridis","year":"2020","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0815","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12974-021-02266-0","article-title":"Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder","volume":"18","author":"Ma","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103033","article-title":"Physical exercise therapy for autoimmune neuroinflammation: application of knowledge from animal models to patient care","volume":"21","author":"Einstein","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb0825","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.4103\/1673-5374.335827","article-title":"Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases","volume":"17","author":"Wang","year":"2022","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0830","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/jnnp-2019-321849","article-title":"Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies","volume":"91","author":"Tholance","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2022.103166_bb0835","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.820760","article-title":"Undifferentiated connective tissue disease in pregnancy: a topic yet to be explored","volume":"13","author":"Serena","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2022.103166_bb0840","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.626258","article-title":"The influence of treatment of inflammatory arthritis during pregnancy on the long-term children\u2019s outcome","volume":"12","author":"Nalli","year":"2021","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0845","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2022.103166_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.842451","article-title":"Circulating levels of anti-C1q and anti-factor H autoantibodies and their targets in normal pregnancy and preeclampsia","volume":"13","author":"Dijkstra","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0855","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2017.08.002","article-title":"Association of serum autoantibodies with pregnancy outcome of patients undergoing first IVF\/ICSI treatment: A prospective cohort study","volume":"122","author":"Chen","year":"2017","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0860","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.827735","article-title":"The detrimental effect of thyroiditis on pregnancy outcome of patients affected by autoimmune diseases: an open question","volume":"13","author":"Botta","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.autrev.2022.103166_bb0865","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnbeh.2018.00230","article-title":"Increasing role of maternal immune activation in neurodevelopmental disorders","volume":"12","author":"Boulanger-Bertolus","year":"2018","journal-title":"Front Behav Neurosci"},{"issue":"21","key":"10.1016\/j.autrev.2022.103166_bb0870","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111516","article-title":"The role of maternal immune activation in the pathogenesis of autism: a review of the evidence, proposed mechanisms and implications for treatment","volume":"22","author":"Zawadzka","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2022.103166_bb0875","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bbi.2021.09.004","article-title":"Double trouble: prenatal immune activation in stress sensitive offspring","volume":"99","author":"Murlanova","year":"2022","journal-title":"Brain Behav Immun"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0880","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3899\/jrheum.181460","article-title":"Pregnancy in systemic sclerosis: results of a systematic review and metaanalysis","volume":"47","author":"Blagojevic","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0885","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0890","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1515\/cclm-2020-1822","article-title":"Pediatric evaluation of clinical specificity and sensitivity of SARS-CoV-2 IgG and IgM serology assays","volume":"59","author":"Bohn","year":"2021","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2022.103166_bb0895","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keac103","article-title":"Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications","author":"Heshin-Bekenstein","year":"2022","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0900","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/1744666X.2022.2010546","article-title":"Breast implant illness: scientific evidence of its existence","volume":"18","author":"Cohen Tervaert","year":"2022","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2022.103166_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102631","article-title":"Autoimmune dysautonomia in women with silicone breast implants","volume":"120","author":"Halpert","year":"2021","journal-title":"J Autoimmun"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/biom12060776","article-title":"Cognitive impairment, sleep disturbance, and depression in women with silicone breast implants: association with autoantibodies against autonomic nervous system receptors","volume":"12","author":"Tocut","year":"2022","journal-title":"Biomolecules."},{"issue":"7","key":"10.1016\/j.autrev.2022.103166_bb0915","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203316686406","article-title":"Autoimmune\/inflammatory syndrome induced by adjuvants (Shoenfeld\u2019s syndrome) - an update","volume":"26","author":"Watad","year":"2017","journal-title":"Lupus."},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0920","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10067-022-06149-4","article-title":"Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?","volume":"41","author":"Jara","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb0925","article-title":"In response to comment on \u201cAutoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune\/inflammatory syndrome expand?\u201d by Jara LJ et al","author":"Jara","year":"2022","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103071","article-title":"The autonomic aspects of the post-COVID19 syndrome","volume":"21","author":"Dotan","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0935","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2010.07.003","article-title":"\u2018ASIA\u2019 - autoimmune\/inflammatory syndrome induced by adjuvants","volume":"36","author":"Shoenfeld","year":"2011","journal-title":"J Autoimmun"},{"issue":"7876","key":"10.1016\/j.autrev.2022.103166_bb0940","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","article-title":"The tangled history of mRNA vaccines","volume":"597","author":"Dolgin","year":"2021","journal-title":"Nature."},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb0945","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12016-013-8385-8","article-title":"Everything is autoimmune until proven otherwise","volume":"45","author":"Shoenfeld","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"issue":"9","key":"10.1016\/j.autrev.2022.103166_bb0950","doi-asserted-by":"crossref","first-page":"102603","DOI":"10.1016\/j.autrev.2020.102603","article-title":"Gulf war illness, post-HPV vaccination syndrome, and Macrophagic Myofasciitis. Similar disabling conditions possibly linked to vaccine-induced autoimmune dysautonomia","volume":"19","author":"Martinez-Lavin","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"29","key":"10.1016\/j.autrev.2022.103166_bb0955","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.2174\/138161211798157540","article-title":"Update on intravenous immunoglobulins (IVIg) mechanisms of action and off- label use in autoimmune diseases","volume":"17","author":"Katz","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0960","doi-asserted-by":"crossref","first-page":"103019","DOI":"10.1016\/j.autrev.2021.103019","article-title":"Efficacy of intravenous immunoglobulin in autoimmune neurological diseases. Literature systematic review and meta-analysis","volume":"21","author":"Morales-Ruiz","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103166_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108615","article-title":"Efficacy of high-dose intravenous immunoglobulin in severe and critical COVID-19: A retrospective cohort study","volume":"106","author":"Aggarwal","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2022.103166_bb0970","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.936734","article-title":"Case series of successful intravenous immunoglobulin (IVIG) treatment in 4 pregnant patients with severe COVID-19-induced hypoxia","volume":"23","author":"Geriak","year":"2022","journal-title":"Am J Case Rep"},{"key":"10.1016\/j.autrev.2022.103166_bb0975","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.746639","article-title":"Diagnostic approach to pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): a narrative review of literature data","volume":"9","author":"Prato","year":"2021","journal-title":"Front Pediatr"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb0980","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.115592","article-title":"Parvovirus B19 infection is associated with autoimmune thyroid disease in adults","volume":"19","author":"Heidari","year":"2021","journal-title":"Int J Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.autrev.2022.103166_bb0985","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/mrcr\/rxab032","article-title":"COVID-19 and adult-onset Still\u2019s disease as part of hyperferritinemic syndromes","volume":"6","author":"Kawasaki","year":"2022","journal-title":"Mod Rheumatol Case Rep"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb0990","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ibd\/izab083","article-title":"Randomized controlled trial of cognitive-behavioral and mindfulness-based stress reduction on the quality of life of patients with crohn disease","volume":"28","author":"Goren","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2022.103166_bb0995","series-title":"Immune Reconstitution Inflammatory Syndrome","author":"Thapa","year":"2022"},{"issue":"8","key":"10.1016\/j.autrev.2022.103166_bb1000","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.autrev.2014.04.005","article-title":"Autoimmune diseases in HIV-infected patients: 52 cases and literature review","volume":"13","author":"Iordache","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103166_bb1005","article-title":"Graves\u2019 disease associated with HIV disease and late immune reconstitution inflammatory syndrome following the initiation of antiretroviral therapy","volume":"2021","author":"Ludgate","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.autrev.2022.103166_bb1010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fmolb.2019.00120","article-title":"Targeted metabolomic analysis of serum fatty acids for the prediction of autoimmune diseases","volume":"6","author":"Tsoukalas","year":"2019","journal-title":"Front Mol Biosci"},{"issue":"12","key":"10.1016\/j.autrev.2022.103166_bb1015","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11120812","article-title":"Metabolomics in autoimmune diseases: focus on rheumatoid arthritis, systemic lupus erythematous, and multiple sclerosis","volume":"11","author":"Yoon","year":"2021","journal-title":"Metabolites."},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb1020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00405-020-05812-3","article-title":"Mucous membrane pemphigoid-otorhinolaryngological manifestations: a retrospective cohort study","volume":"277","author":"Madgar","year":"2020","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb1025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.ico.0000178730.34564.c7","article-title":"Mucous membrane pemphigoid with fatal bronchial involvement in a seventeen-year-old girl","volume":"25","author":"Gamm","year":"2006","journal-title":"Cornea."},{"issue":"4","key":"10.1016\/j.autrev.2022.103166_bb1030","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/LBR.0000000000000374","article-title":"Mucous membrane pemphigoid causing central airway obstruction","volume":"24","author":"Jalil","year":"2017","journal-title":"J Bronchol Interv Pulmonol"},{"issue":"2","key":"10.1016\/j.autrev.2022.103166_bb1035","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2340\/00015555-1659","article-title":"A case of mucous membrane pemphigoid involving the trachea and bronchus with autoantibodies to beta3 subunit of laminin-332","volume":"94","author":"Kato","year":"2014","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb1040","first-page":"325","article-title":"Sarcoidosis: a review for the internist","volume":"13","author":"Bargagli","year":"2018","journal-title":"Intern Emerg Med"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb1045","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/aos.12939","article-title":"Prevalence and clinical impact of antiretinal antibodies in uveitis","volume":"94","author":"Ten Berge","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb1050","first-page":"638","article-title":"Review of IgG4-related disease","volume":"42","author":"Sanchez-Oro","year":"2019","journal-title":"Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.autrev.2022.103166_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102646","article-title":"Update on IgG4-mediated autoimmune diseases: new insights and new family members","volume":"19","author":"Koneczny","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103166_bb1060","article-title":"Anti-neuronal IgG4 autoimmune diseases and IgG4-related diseases may not be part of the same spectrum: a comparative study","volume":"12","author":"Endmayr","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2022.103166_bb1065","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/nutrit\/nuab039","article-title":"Gluten-free diet can ameliorate the symptoms of non-celiac autoimmune diseases","volume":"80","author":"Lerner","year":"2022","journal-title":"Nutr Rev"},{"issue":"5","key":"10.1016\/j.autrev.2022.103166_bb1070","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s10067-022-06066-6","article-title":"Exploring cannabis use and perspectives among psoriatic disease patients","volume":"41","author":"Tsang","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2022.103166_bb1075","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.clim.2016.02.004","article-title":"Increased soluble CD72 in systemic lupus erythematosus is in association with disease activity and lupus nephritis","volume":"164","author":"Vadasz","year":"2016","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2022.103166_bb1080","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.semarthrit.2013.11.010","article-title":"A regulatory role for CD72 expression on B cells in systemic lupus erythematosus","volume":"43","author":"Vadasz","year":"2014","journal-title":"Semin Arthritis Rheum"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:25:28Z","timestamp":1761600328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":216,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S1568997222001367"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103166","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mosaic of autoimmunity \u2013 Finally discussing in person. The 13th international congress on autoimmunity 2022 (AUTO13) Athens","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103166","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103166"}}